IGF1 and neoplasm: The researchers discovered that tumors from Pik3cap.H1047R tumor-bearing mice treated with a PI3K inhibitor exhibited PANK4 phosphorylation and tumor growth in a PI3K-dependent manner; similar effects were observed in the skeletal muscle of non-tumor-bearing mice and in IGF-1–stimulated cells.